Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Degano

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The European Respiratory Journal|September 19, 2008
Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertensionB Degano, A Yaïci, J Le Pavec, et al.
Respiratory Medicine and Research|February 9, 2020
Quantitative and qualitative evaluation of spirometry for COPD screening in general practiceT Soumagne, A Guillien, P Roux, et al.
The European Respiratory Journal|June 23, 2009
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive diseaseD Montani, X Jaïs, L C Price, et al.
Revue Des Maladies Respiratoires|December 4, 2012
[COPD in dairy farmers: screening, characterization and constitution of a cohort. The BALISTIC study]B Degano, M Bouhaddi, J-J Laplante, et al.
Revue Des Maladies Respiratoires|February 24, 2015
Contribution of exhaled nitric oxide measurement in airway inflammation assessment in asthma. A position paper from the French Speaking Respiratory SocietyA T Dinh-Xuan, I Annesi-Maesano, P Berger, et al.
Revue Des Maladies Respiratoires|August 12, 2018
[Guidelines for methacholine provocation testing]L Plantier, N Beydon, A Chambellan, et al.
Revue Des Maladies Respiratoires|March 16, 2005
[Biomarkers as prognostic factors in pulmonary arterial hypertension. Rationale and study design]J L Cracowski, A Yaici, O Sitbon, et al.
Revue Des Maladies Respiratoires|May 14, 2022
[Take-home messages from the COPD 2021 biennial of the French Society of Respiratory Diseases. Understanding to so as to better innovate]J Ancel, M Guecamburu, V Marques Da Silva, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2024
H<sub>2</sub> inhalation therapy in patients with moderate COVID-19 (H<sub>2</sub>COVID): a prospective ascending-dose phase I clinical trialC Salomez-Ihl, J Giai, M Barbado, et al.
Revue Des Maladies Respiratoires|May 14, 2021
[Pharmacological treatment optimisation in patients with stale COPD. Position of the French-language Respiratory Society. 2021 Update]M Zysman, B Ribeiro Baptista, T Soumagne, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The European Respiratory Journal|September 19, 2008
Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertensionB Degano, A Yaïci, J Le Pavec, et al.
Respiratory Medicine and Research|February 9, 2020
Quantitative and qualitative evaluation of spirometry for COPD screening in general practiceT Soumagne, A Guillien, P Roux, et al.
The European Respiratory Journal|June 23, 2009
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive diseaseD Montani, X Jaïs, L C Price, et al.
Revue Des Maladies Respiratoires|December 4, 2012
[COPD in dairy farmers: screening, characterization and constitution of a cohort. The BALISTIC study]B Degano, M Bouhaddi, J-J Laplante, et al.
Revue Des Maladies Respiratoires|February 24, 2015
Contribution of exhaled nitric oxide measurement in airway inflammation assessment in asthma. A position paper from the French Speaking Respiratory SocietyA T Dinh-Xuan, I Annesi-Maesano, P Berger, et al.
Revue Des Maladies Respiratoires|August 12, 2018
[Guidelines for methacholine provocation testing]L Plantier, N Beydon, A Chambellan, et al.
Revue Des Maladies Respiratoires|March 16, 2005
[Biomarkers as prognostic factors in pulmonary arterial hypertension. Rationale and study design]J L Cracowski, A Yaici, O Sitbon, et al.
Revue Des Maladies Respiratoires|May 14, 2022
[Take-home messages from the COPD 2021 biennial of the French Society of Respiratory Diseases. Understanding to so as to better innovate]J Ancel, M Guecamburu, V Marques Da Silva, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2024
H<sub>2</sub> inhalation therapy in patients with moderate COVID-19 (H<sub>2</sub>COVID): a prospective ascending-dose phase I clinical trialC Salomez-Ihl, J Giai, M Barbado, et al.
Revue Des Maladies Respiratoires|May 14, 2021
[Pharmacological treatment optimisation in patients with stale COPD. Position of the French-language Respiratory Society. 2021 Update]M Zysman, B Ribeiro Baptista, T Soumagne, et al.
Pageof 5